Browsing Tag
Netherton Syndrome
3 posts
Quoin Pharmaceuticals (NASDAQ: QNRX) spikes over 50% after rapamycin breakthrough in rare disease program
Quoin Pharmaceuticals (NASDAQ: QNRX) stock surged over 50% after achieving key rapamycin delivery targets. Find out how this positions its rare disease pipeline.
QRX003 by Quoin Pharmaceuticals earns FDA orphan drug designation, signaling hope for Netherton Syndrome patients
Find out how Quoin Pharmaceuticals is changing rare-disease treatment today with its QRX003 orphan drug win — read more now!
Quoin Pharmaceuticals raises up to $104.5M in private placement to fuel its rare disease pipeline
Find out how Quoin Pharmaceuticals secured up to $104.5 million in a milestone-linked private placement to advance its rare disease therapy QRX003 and strengthen investor confidence.